Last updated: April 17, 2024
Sponsor: Stony Brook University
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Diabetes Mellitus, Type 2
Treatment
Dexcom G6 Pro Continuous Glucose Monitor (CGM)
Clinical Study ID
NCT05666479
IRB2021-00351
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Greater than or equal to 18 years of age
- Scheduled for elective inpatient hip or knee replacement surgery at Stony BrookUniversity Hospital (SBUH)
- Clinically diagnosed Type 2 Diabetes at least 6 months prior to surgery
- Literate and able to provide written informed consent
- Negative pregnancy test by serum or urine HCG at screening [as documented in subject'smedical record) for women of childbearing potential (WCBP)]
Exclusion
Exclusion Criteria:
- Less than 18 years of age
- Not scheduled for elective inpatient hip or knee replacement surgery at SBUH
- No clinical diagnosis of Type 2 diabetes at least 6 months prior to surgery
- Not literate or unable to provide written informed consent
- Documented diagnosis of organ failure
- Documented diagnosis of chronic infection
- Documented diagnosis of any active malignancy
- Documented diagnosis of hepatic (liver) dysfunction or cirrhosis
- Pregnant by serum or urine HCG at screening [as documented in subject's medicalrecord) for women of childbearing potential (WCBP)]
Study Design
Total Participants: 32
Treatment Group(s): 1
Primary Treatment: Dexcom G6 Pro Continuous Glucose Monitor (CGM)
Phase:
Study Start date:
September 09, 2022
Estimated Completion Date:
September 30, 2024
Connect with a study center
Stony Brook University
Stony Brook, New York 11794
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.